Area of research
Internal Medicine · Epidemiology
Research interest
Risk factors for heart disease, stroke, cognitive impairment / dementia, and venous thrombosis. Connections between cardiovascular and brain health, and vascular origins of cognitive impairment. BIO Dr. Cushman studies risk factors for heart disease, stroke, cognitive impairment / dementia, venous thrombosis and risk factors for these using molecular epidemiology approaches. She is interested in the connections of cardiovascular and brain health, and vascular origins of cognitive impairment. During the pandemic, Dr. Cushman engaged in designing and conducting treatment trials in COVID-19 and studies of COVID-19 epidemiology. She has held leadership roles in a number of NIH-funded observational epidemiology studies, notably the Reasons for Geographic and Racial Differences in Stroke (REGARD
Antiphospholipid antibodies and cardiovascular thrombosis
Impact of Venous Thrombosis Prevention in Ambulatory Oncology: Importance of Guideline Adherence.
Circulating biomarkers and mortality in atrial fibrillation: the REasons for Geographic And Racial Differences in Stroke study.
Blood Biomarkers and the Risk of Coronary Disease in Atrial Fibrillation.
Associations between plasma levels of coagulation factors VIII and IX and incident cardiovascular disease and mortality: systematic review and meta-analysis
Circulating Biomarkers of Neurodegeneration and All-Cause and Dementia-Specific Mortality.
Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals
Genetic Architecture of N-Terminal Pro-B-Type Natriuretic Peptide in a Multiancestry Study Population
Life's Essential 8 and Risk of Severe COVID-19 Among Adults Without Clinical Cardiovascular Disease: The C4R Study.
Novel Plasma Proteomic Markers and Risk of Venous Thromboembolism
Air pollution is associated with increased risk of venous thromboembolism: the Multi-Ethnic Study of Atherosclerosis.
Association of Duration of Recognized Hypertension and Stroke Risk: The REGARDS Study.
Improving stroke risk prediction in atrial fibrillation with circulating biomarkers: the CHA2DS2-VASc–Biomarkers model
Discordance in Creatinine- and Cystatin C–Based eGFR and Clinical Outcomes
COVID-19 and Cognitive Change in a Community-Based Cohort
Improving stroke risk prediction in atrial fibrillation with circulating biomarkers: the CHA2DS2-VASc–Biomarkers model
Defining Kidney Health Dimensions and Their Associations with Adverse Outcomes in Persons with Diabetes and CKD
Circulating Biomarkers of Neurodegeneration and Risk of Cognitive Impairment
Targeted Metabolomics in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
Circulating Biomarkers of Neurodegeneration and Risk of Cognitive Impairment.
Circulating biomarkers and ischemic stroke risk in adults with atrial fibrillation taking anticoagulation: the Reasons for Geographic And Racial Differences in Stroke study
Soluble receptor for advanced glycation end products and diabetes in Black and White Americans: the REGARDS Study.
Residential Racial Segregation, Socioeconomic Status, and Hypertension Risk in Black and White Americans: The REGARDS Prospective Cohort Study.
Inflammation and Cognitive Decline: A Population-Based Cohort Study Among Aging Adults With Atrial Fibrillation.
N-terminal Pro-B-Type Natriuretic Peptide and Risk for Diabetes Mellitus and Metabolic Syndrome.
Association of Transthyretin Valine to Isoleucine Variant with Kidney Outcomes in Community-Dwelling Black Adults: The Reasons for Geographic and Racial Differences in Stroke Cohort.
On-Treatment Change in d-Dimer Is Associated With Differential Outcomes Among Therapeutic Dose Heparin-Treated Noncritically Ill Patients Hospitalized for COVID-19.
Abstract 4364062: Urban-Rural Differences in Life’s Essential 8: Results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) Study
Genetic drivers of heterogeneity in type 2 diabetes pathophysiology
Epidemiologic Features of Recovery From SARS-CoV-2 Infection